Ricerca

Pubblicazioni IRIS

• Dupilumab Effectiveness in Patients with Severe Allergic Asthma Non-Responsive to Omalizumab
  Anno: 2025
• Unlocking the Long-Term Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A Three-Year Real-Life Study
  Anno: 2024
• SANI clinical remission definition: a useful tool in severe asthma management
  Anno: 2024
• Thymic Stromal Lymphopoietin and Tezepelumab in Airway Diseases: From Physiological Role to Target Therapy
  Anno: 2024
• Triple inhaled therapy in asthma: Beliefs, behaviours and doubts
  Anno: 2024